Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor

  • Read more about Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor
Japan
2022-185113
Filed on 2022-11-18

AUTOMATIC SYSTEM AND METHOD FOR TISSUE SECTIONING, STAINING, AND SCANNING

  • Read more about AUTOMATIC SYSTEM AND METHOD FOR TISSUE SECTIONING, STAINING, AND SCANNING
Patent Cooperation Treaty
PCT/US2022/046406
Filed on 2022-10-12

IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF

  • Read more about IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF
Patent Cooperation Treaty
PCT/US2022/079554
Filed on 2022-11-09

Combination Therapy of Immunotoxin and Checkpoint Inhibitor

  • Read more about Combination Therapy of Immunotoxin and Checkpoint Inhibitor
Hong Kong
42022061535.5
Filed on 2022-09-30

Mab 15B6 Blocks Mesothelin Shedding And Makes Very Active CAR-T Cell And BITE

  • Read more about Mab 15B6 Blocks Mesothelin Shedding And Makes Very Active CAR-T Cell And BITE
Patent Cooperation Treaty
PCT/US2022/081766
Filed on 2022-12-16

IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN

  • Read more about IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN
European Patent
20882104.1
Filed on 2020-10-29

MODIFIED CELLS AND METHODS OF THERAPY

  • Read more about MODIFIED CELLS AND METHODS OF THERAPY
Israel
295616
Filed on 2022-08-15

Chimeric Antigen Receptors Targeting B-cell Maturation Antigen

  • Read more about Chimeric Antigen Receptors Targeting B-cell Maturation Antigen
US Patent 11,827,889
Filed on 2022-10-06

Methods of Preparing Anti-human Papillomavirus Antigen T Cells

  • Read more about Methods of Preparing Anti-human Papillomavirus Antigen T Cells
United Kingdom
19209253.4
Filed on 2019-11-14

Methods of Preparing Anti-human Papillomavirus Antigen T Cells

  • Read more about Methods of Preparing Anti-human Papillomavirus Antigen T Cells
Spain
19209253.4
Filed on 2019-11-14

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 281
  • Page 282
  • Page 283
  • Page 284
  • Page 285
  • Page 286
  • Page 287
  • Page 288
  • Page 289
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health